Ovarian cancer needs to be identified from benign tumours, in order to reduce the number of surgeries keeping high sensitivity for malign tumours. The main aim is to review published data that has used GIRADS classification. Pubmed database was searched with the term “GIRADS”. Number of cases in each GIRADS stage and the correlation with pathology was reviewed. Heterogenity analysis was performed. Six studies were published. At all, 2460 ovarian masses were included, from which, 436 were malignant. The prevalence of malignant tumours was 19.7 % (95% IC 11-29). The sensitivity and specificity was 96% (91-98% I2=71%,) and 91% (95% IC 86-95). The positive predictive value was 73% (95%IC 67-79). The GIRADS classification has increased its use and its performance has been shown to be good. This meta-analysis supports its use and affirms that this method is clinically useful and practical to avoid unnecessary surgeries in women. Supporting information can be found in the online version of this abstract Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.